EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis

Jason Y Zhang, Jason Xiao, Bingqing Xie, Hugo Barba, Michael Boachie-Mensah, Rohan N Shah, Urooba Nadeem, Melanie Spedale, Nicholas Dylla, Huaiying Lin, Ashley M Sidebottom, Mark D'Souza und 4 weitere

Investigative Opthalmology & Visual Science · 18.12.2023 · 64 (15) · 21

DOI: 10.1167/iovs.64.15.21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 18.12.2023. Verfasst von Jason Y Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States. Hauptthemen laut MEDLINE: Wet Macular Degeneration, Choroidal Neovascularization. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Emerging data indicate that metformin may prevent the development of age-related macular degeneration (AMD). Whereas the underlying mechanisms of metformin's anti-aging properties remain undetermined, one proposed avenue is the gut microbiome. Using the laser-induced choroidal neovascularization (CNV) model, we investigate the effects of oral metformin on CNV, retinal pigment epithelium (RPE)/choroid transcriptome, and gut microbiota.

Methods

Specific pathogen free (SPF) male mice were treated via daily oral gavage of metformin 300 mg/kg or vehicle. Male mice were selected to minimize sex-specific differences to laser induction and response to metformin. Laser-induced CNV size and macrophage/microglial infiltration were assessed by isolectin and Iba1 immunostaining. High-throughput RNA-seq of the RPE/choroid was performed using Illumina. Fecal pellets were analyzed for gut microbiota composition/pathways with 16S rRNA sequencing/shotgun metagenomics, as well as microbial-derived metabolites, including small-chain fatty acids and bile acids. Investigation was repeated in metformin-treated germ-free (GF) mice and antibiotic-treated/GF mice receiving fecal microbiota transplantation (FMT) from metformin-treated SPF mice.

Results

Metformin treatment reduced CNV size (P < 0.01) and decreased Iba1+ macrophage/microglial infiltration (P < 0.005). One hundred forty-five differentially expressed genes were identified in the metformin-treated group (P < 0.05) with a downregulation in pro-angiogenic genes Tie1, Pgf, and Gata2. Furthermore, metformin altered the gut microbiome in favor of Bifidobacterium and Akkermansia, with a significant increase in fecal levels of butyrate, succinate, and cholic acid. Metformin did not suppress CNV in GF mice but colonization of microbiome-depleted mice with metformin-derived FMT suppressed CNV.

Conclusions

These data suggest that oral metformin suppresses CNV, the hallmark lesion of advanced neovascular AMD, via gut microbiome modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wet Macular DegenerationChoroidal NeovascularizationMaleFemaleAnimalsMiceAngiogenesis InhibitorsRNA, Ribosomal, 16SVascular Endothelial Growth Factor AVisual AcuityRetina

Substanzen

Angiogenesis InhibitorsRNA, Ribosomal, 16SVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States.
  • Department of Medicine, University of Chicago, Chicago, Illinois, United States.
  • Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois, United States.
  • Department of Pathology, University of Chicago, Chicago, Illinois, United States.
  • Animal Resources Center, University of Chicago, University of Chicago, Chicago, Illinois, United States.
  • Duchossois Family Institute, University of Chicago, Chicago, Illinois, United States.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Zhang, J. Y., Xiao, J., Xie, B., Barba, H., Boachie-Mensah, M., Shah, R. N., Nadeem, U., Spedale, M., Dylla, N., Lin, H., Sidebottom, A. M., D'Souza, M., Theriault, B., Sulakhe, D., Chang, E. B., & Skondra, D. (2023). Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis. Investigative Opthalmology & Visual Science, 64(15), 21. https://doi.org/10.1167/iovs.64.15.21

Vancouver

Zhang JY, Xiao J, Xie B, Barba H, Boachie-Mensah M, Shah RN, et al. Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis. Investigative Opthalmology & Visual Science. 2023;64(15):21. doi:10.1167/iovs.64.15.21

BibTeX
@article{Zhang2023,
  author = {Zhang, Jason Y and Xiao, Jason and Xie, Bingqing and Barba, Hugo and Boachie-Mensah, Michael and Shah, Rohan N and Nadeem, Urooba and Spedale, Melanie and Dylla, Nicholas and Lin, Huaiying and Sidebottom, Ashley M and D'Souza, Mark and Theriault, Betty and Sulakhe, Dinanath and Chang, Eugene B and Skondra, Dimitra},
  title = {Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  volume = {64},
  number = {15},
  pages = {21},
  doi = {10.1167/iovs.64.15.21}
}
Kostenlos starten →